A Comparison Study to Determine the Increased Efficacy of Adding EMEND to the Treatment Regimen for Post-Discharge and Post-Operative Nausea and Vomiting.

Trial Profile

A Comparison Study to Determine the Increased Efficacy of Adding EMEND to the Treatment Regimen for Post-Discharge and Post-Operative Nausea and Vomiting.

Withdrawn prior to enrolment
Phase of Trial: Phase III

Latest Information Update: 02 Feb 2018

At a glance

  • Drugs Aprepitant (Primary) ; Antiemetics
  • Indications Nausea and vomiting; Postoperative nausea and vomiting
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Jan 2018 Planned primary completion date changed from 1 Oct 2011 to 1 Jan 2011.
    • 29 Jan 2018 Status changed from not yet recruiting to withdrawn prior to enrolment.
    • 05 Sep 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top